Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha
Cancer is one of the main causes of human mortality worldwide and novel chemotherapeutics are required due to the limitations of conventional cancer therapies. For example, using redox selenium compounds as novel chemotherapeutics seem to be very promising. The objective of this study was to explore...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021-06-01
|
| シリーズ: | Heliyon |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2405844021013578 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|